Halozyme Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HALO and other ETFs, options, and stocks.About HALO
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence.
CEOHelen I. Torley
CEOHelen I. Torley
Employees373
Employees373
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1998
Founded1998
Employees373
Employees373
HALO Key Statistics
Market cap5.77B
Market cap5.77B
Price-Earnings ratio18.77
Price-Earnings ratio18.77
Dividend yield—
Dividend yield—
Average volume1.21M
Average volume1.21M
High today$46.16
High today$46.16
Low today$45.22
Low today$45.22
Open price$45.77
Open price$45.77
Volume1.03M
Volume1.03M
52 Week high$46.16
52 Week high$46.16
52 Week low$31.86
52 Week low$31.86
HALO News
Yahoo Finance 20h
Here's Why Halozyme Therapeutics is a Strong Growth Stock - Yahoo FinanceIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. While you...
Investor's Business Daily 1d
Halozyme Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating - Investor's Business DailyHalozyme Therapeutics (HALO) had its Relative Strength (RS) Rating upgraded from 80 to 84 Thursday. X IBD's unique RS Rating identifies market leadership by us...
Investor's Business Daily 7d
Biotech Stocks To Watch: Halozyme Actionable Now After Earnings-Fueled BreakoutAmong top biotech stocks to watch, Halozyme Therapeutics (HALO) is trading inside a buy zone after a breakout. X San Diego-based Halozyme is the maker of the...
Analyst ratings
82%
of 11 ratingsBuy
81.8%
Hold
18.2%
Sell
0%